Surgical Cytoreduction Followed by Intraoperative Intrathoracic Hyperthermic Chemotherapy Perfusion for the Management of Disseminated Pleural Malignancies
Interventional
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Time to disease progression
Most cancers that have spread to the chest cavity have limited survival. Response to systemic chemotherapy and radiation therapy is short-lived. This end point will determine the time to disease progression of this experimental treatment modality.
1 year
No
Cliff P Connery, MD
Principal Investigator
St. Luke's-Roosevelt Hospital Center, Division of Thoracic Surgery
United States: Institutional Review Board
SLR IRB#09-207
NCT01163552
June 2010
June 2013
Name | Location |
---|---|
St. Luke's-Roosevelt Hospital Center | New York, New York |